Skip to main content

Table 7 Crosstabulation chemotherapy/tumor entity

From: Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years

 

Tumor entity

Total

ALT

DLS

MLS

PLS

LSM

Chemotherapy

Yes

Number of patients

0

5

6

6

0

17

% of chemotherapy

0,0%

29,4%

35,3%

35,3%

0,0%

100,0%

No

Number of patients

56

16

32

6

1

111

% of chemotherapy

50,5%

14,4%

28,8%

5,4%

0,9%

100,0%

Total

Number of patients

56

21

38

12

1

128

% of chemotherapy

43,8%

16,4%

29,7%

9,4%

0,8%

100,0%

  1. ALT Atypical lipomatous tumour, DLS Dedifferentiated liposarcoma, MLS Myxoid liposarcoma, PLS Pleomorphic liposarcoma, LSM Mixed-type liposarcoma